Management of Recurrent Syncope with Normal Cardiac Workup and Family History of WPW
Given the normal echocardiogram, event monitor showing no arrhythmic correlation with symptoms, and temporal relationship with sertraline dose escalation, the most appropriate next step is to refer to electrophysiology (EP) for risk stratification of potential WPW syndrome given the family history, while simultaneously evaluating the sertraline as a potential contributor to symptoms.
Risk Stratification for WPW Syndrome
The family history of WPW in a first-degree relative is a significant red flag that requires thorough evaluation, even with a normal event monitor 1:
EP referral is essential because younger patients with WPW can present with syncope rather than typical palpitations, and the syndrome carries a small but significant risk of sudden cardiac death from rapid ventricular response during atrial fibrillation 1, 2, 3.
The 2017 ACC/AHA/HRS guidelines emphasize that evaluation of syncope in patients with potential WPW requires thorough history to differentiate arrhythmic from non-arrhythmic syncope (such as vasovagal syncope), particularly in younger patients 1.
A standard 12-lead ECG should be carefully reviewed for any evidence of pre-excitation pattern (short PR interval, delta wave), which may be intermittent and was potentially missed 1, 4, 3.
Even patients with intermittent pre-excitation, once thought to be at minimal risk, may still carry significant risk 4.
Electrophysiology Study Considerations
EP study with exercise testing is recommended for risk stratification in this clinical context 1, 4:
Exercise testing can identify whether pre-excitation disappears with increased heart rate, which has high negative predictive value for risk 4.
If an accessory pathway is identified, EP study can determine the refractory period of the pathway, with shortest pre-excited R-R interval during induced atrial fibrillation <250 ms indicating higher risk 4, 2.
Catheter ablation is the definitive treatment if WPW syndrome is confirmed, with excellent success rates and minimal risk, effectively eliminating both symptom burden and sudden death risk 5, 2, 3.
Sertraline Evaluation
The temporal relationship between sertraline dose increase (50 mg to 75 mg) and symptom onset warrants careful consideration 6:
Common side effects of sertraline include dizziness, which could contribute to lightheadedness and presyncope 6.
The FDA labeling specifically warns about monitoring for new or worsening symptoms when sertraline dose is changed 6.
However, sertraline should not be abruptly discontinued without psychiatric consultation, as stopping too quickly can cause serious withdrawal symptoms including dizziness and confusion 6.
Consider psychiatric consultation to evaluate whether dose reduction back to 50 mg is appropriate while maintaining adequate treatment of the underlying psychiatric condition 6.
Vasovagal Syncope Remains on Differential
The clinical presentation has features consistent with vasovagal syncope 1:
Younger age, syncope only while standing, and situational triggers (doing friend's hair) are more often associated with non-cardiac causes 1.
The event monitor showing 13 symptom episodes correlating with sinus rhythm or sinus tachycardia (not arrhythmia) supports a non-arrhythmic etiology 1, 7.
However, the 2017 guidelines note that palpitations can precede vasovagal faints due to sinus tachycardia, so the presence of palpitations doesn't exclude this diagnosis 1.
Specific Action Plan
Immediate EP referral for exercise testing and potential EP study to definitively rule out WPW syndrome given family history 1, 4, 3.
Psychiatric consultation to evaluate sertraline contribution and consider dose adjustment if clinically appropriate 6.
Educate patient on vasovagal precautions including adequate hydration, recognizing prodromal symptoms, and physical counterpressure maneuvers while awaiting EP evaluation 1.
Avoid AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin) until WPW is definitively excluded, as these can be dangerous if rapid atrial fibrillation occurs through an accessory pathway 1, 2.
Critical Pitfall to Avoid
Do not dismiss the family history of WPW despite the normal event monitor. Accessory pathways may conduct intermittently, and dangerous arrhythmias in WPW (particularly pre-excited atrial fibrillation) may not be captured on ambulatory monitoring 8, 4, 3. The consequences of missing this diagnosis include risk of sudden cardiac death from ventricular fibrillation 8, 4, 2.